Australian NSP Survey Data Reports

Queensland sentinel and non-sentinel NSP sites: Results from the Australian NSP survey 2007

The Australian Needle and Syringe Program (NSP) survey is a cross sectional survey conducted annually at sentinel NSP sites across Australia. The survey forms the basis of human immunodeficiency virus (HIV) and hepatitis C surveillance among injecting drug users (IDUs). Each year, all clients attending selected NSPs during the designated survey week are asked to complete a brief, anonymous questionnaire and to provide a capillary blood sample for HIV and hepatitis C virus (HCV) antibody testing.

Australian NSP Survey National Data Report 2011 – 2015

The Australian Needle and Syringe Program Survey (ANSPS) provides serial point prevalence estimates of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) antibodies and sexual and injecting risk behaviour among people who inject drugs (PWID) in Australia. Conducted annually over a one-two week period in October, all clients attending participating needle and syringe program (NSP) services are invited to complete a brief, anonymous questionnaire and to provide a capillary blood sample for HIV and HCV antibody testing.

Australian NSP Survey National Data Report 2009 – 2013

The Australian Needle and Syringe Program Survey (ANSPS) provides serial point prevalence estimates of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) antibodies and sexual and injecting behavioural risk among people who inject drugs (PWID) in Australia. Conducted annually over a one-two week period in October, all clients attending participating needle and syringe program (NSP) services are invited to complete a brief, anonymous questionnaire and to provide a capillary blood sample for HIV and HCV antibody testing.

Australian NSP Survey National Data Report 2008 – 2012

The Australian Needle and Syringe Program Survey (ANSPS) provides serial point prevalence estimates of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) antibodies and sexual and injecting behavioural risk among people who inject drugs (PWID) in Australia. Conducted annually over a one-two week period in October, all clients attending participating needle and syringe program (NSP) services are invited to complete a brief, anonymous questionnaire and to provide a capillary blood sample for HIV and HCV antibody testing.

Australian NSP Survey National Data Report 2007 – 2011

The Australian Needle and Syringe Program Survey (ANSPS) provides serial point prevalence estimates of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) antibodies and sexual and injecting behavioural indices of risk among people who inject drugs (PWID) in Australia. Conducted annually over a one-two week period in October, all clients attending participating needle and syringe program (NSP) services are invited to complete a brief, anonymous questionnaire and to provide a capillary blood sample for HIV and HCV antibody testing.

Australian NSP Survey National Data Report 2005 – 2009

The Australian Needle and Syringe Program Survey (ANSPS) is a cross-sectional study that has been conducted over a one to two week period each year since 1995. The survey forms the basis of Australia’s human immunodeficiency virus (HIV) and hepatitis C surveillance among injecting drug users, and monitors behavioural indices of risk in addition to prevalence of infection.

Australian NSP Survey National Data Report 2004 – 2008

The Australian Needle and Syringe Program Survey (ANSPS) is a cross-sectional study that has been conducted over a one to two week period each year since 1995. The survey forms the basis of Australia’s human immunodeficiency virus (HIV) and hepatitis C surveillance among injecting drug users, and monitors behavioural indices of risk in addition to prevalence of infection.

Australian NSP Survey National Data Report 2003 – 2007

The Australian Needle and Syringe Program Survey (ANSPS) is a cross-sectional study that has been conducted over a one to two week period each year since 1995. The survey forms the basis of Australia’s human immunodeficiency virus (HIV) and hepatitis C surveillance among injecting drug users, and monitors behavioural indices of risk in addition to prevalence of infection.

Australian NSP Survey National Data Report 1995 – 2002

The Australian Needle and Syringe Program Survey (ANSPS) is a cross-sectional study that has been conducted over a one to two week period each year since 1995. The survey forms the basis of Australia’s human immunodeficiency virus (HIV) and hepatitis C surveillance among injecting drug users, and monitors behavioural indices of risk in addition to prevalence of infection.

Australian NSP Survey National Data Report 1995 – 2014

The Australian Needle and Syringe Program Survey (ANSPS) provides serial point prevalence estimates of exposure to human immunodeficiency virus (HIV) and hepatitis C (HCV) and monitors sexual and injecting behaviour among people who inject drugs (PWID) in Australia. Conducted annually since 1995, Needle and Syringe Programs from all states and territories participate and in 2014, around two thirds of Australia’s ~75 primary NSP services participated in the ANSPS. This report presents national and jurisdictional results over the twenty year period, from 1995 to 2014.

Events